Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Phase II brentuximab vedotin and lenalidomide in relapsed/refractory T-cell lymphomas

Protocol: OSU-17204

Full Title

A phase II study of brentuximab vedotin and lenalidomide in relapsed and refractory T-cell lymphomas

Lymphoma Non-Hodgkin’s Lymphoma (B- & T-Cell) Cutaneous Lymphoma